Answers are grounded in this paper and cite their sources.
Dermatomyositis pathophysiology is complex. In recent years, medical research has identified molecules associated with disease activity. Besides providing insights into the driving mechanisms of dermatomyositis, these findings could provide potential biomarkers. Activity markers can be used to monitor disease activity in clinical trials and may also be useful in daily practice. This article reviews molecules that could be used as biomarkers for diagnosis and monitoring dermatomyositis disease activity.
No takes yet. Share an insight, caveat, or question.
Cassius et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: